Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1812401

Cover Image

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1812401

Psoriasis Treatment Market

PUBLISHED:
PAGES: 242 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5795
PDF (Multi-user License)
USD 8795
PDF (Corporate License)
USD 11795

Add to Cart

Description

Table of Contents

List of Tables

Psoriasis Treatment Market- Scope of Report

TMR's report on the global Psoriasis Treatment Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Psoriasis Treatment Market for the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Psoriasis Treatment Market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Psoriasis Treatment Market .

Market Snapshot
Market Value in 2024US$ 35 Bn
Market Value in 2035US$ 87.6 Bn
CAGR9.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Psoriasis Treatment Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Psoriasis Treatment Market. These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Psoriasis Treatment Market .

The report delves into the competitive landscape of the global Psoriasis Treatment Market. Key players operating in the global Psoriasis Treatment Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Psoriasis Treatment Market profiled in this report.

Key Questions Answered in Global Psoriasis Treatment Market Report:

  • What are the opportunities in the global Psoriasis Treatment Market ?
  • What are the major drivers, restraints, opportunities, and threats in the Market ?
  • Which regional Market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the Market positions of different companies operating in the global Market ?

Psoriasis Treatment Market- Research Objectives and Research Approach

The comprehensive report on the global Psoriasis Treatment Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Psoriasis Treatment Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Psoriasis Treatment Market.

Show more
Product Code: TMRGL17960

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Psoriasis Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Psoriasis Treatment Market Analysis and Forecasts, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Regulatory Landscape across Key Regions / Countries
  • 5.2. Psoriasis Treatment Market Trends
  • 5.3. PORTER's Five Forces Analysis
  • 5.4. PESTEL Analysis
  • 5.5. Key Purchase Metrics for End-users
  • 5.6. Brand and Pricing Analysis
  • 5.7. Treatment Algorithm
  • 5.8. Distributors Landscape

6. Global Psoriasis Treatment Market Analysis and Forecasts, By Drug Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Drug Type, 2020 to 2035
    • 6.3.1. Biologics
      • 6.3.1.1. TNF Inhibitors
      • 6.3.1.2. Interleukin Inhibitors
        • 6.3.1.2.1. IL-17 Inhibitors
        • 6.3.1.2.2. IL-23 Inhibitors
        • 6.3.1.2.3. Others
    • 6.3.2. Small Molecule Drugs
      • 6.3.2.1. Tyrosine kinase 2 (TYK2) inhibitors
      • 6.3.2.2. Phosphodiesterase 4 (PDE4) inhibitor
      • 6.3.2.3. Corticosteroids
      • 6.3.2.4. Retinoids
      • 6.3.2.5. Calcineurin inhibitors
      • 6.3.2.6. Others
  • 6.4. Market Attractiveness By Drug Type

7. Global Psoriasis Treatment Market Analysis and Forecasts, By Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Type, 2020 to 2035
    • 7.3.1. Branded
    • 7.3.2. Generic
  • 7.4. Market Attractiveness By Type

8. Global Psoriasis Treatment Market Analysis and Forecasts, By Types of Psoriasis

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Types of Psoriasis, 2020 to 2035
    • 8.3.1. Plaque Psoriasis
    • 8.3.2. Inverse Psoriasis
    • 8.3.3. Guttate Psoriasis
    • 8.3.4. Pustular Psoriasis
    • 8.3.5. Others
  • 8.4. Market Attractiveness By Types of Psoriasis

9. Global Psoriasis Treatment Market Analysis and Forecasts, By Route of Administration

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Route of Administration, 2020 to 2035
    • 9.3.1. Oral
    • 9.3.2. Topical
    • 9.3.3. Parenteral
  • 9.4. Market Attractiveness By Route of Administration

10. Global Psoriasis Treatment Market Analysis and Forecasts, By Distribution Channel

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast By Distribution Channel, 2020 to 2035
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Pharmacies
  • 10.4. Market Attractiveness By Distribution Channel

11. Global Psoriasis Treatment Market Analysis and Forecasts, By Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast By Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness By Region

12. North America Psoriasis Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Drug Type, 2020 to 2035
    • 12.2.1. Biologics
      • 12.2.1.1. TNF Inhibitors
      • 12.2.1.2. Interleukin Inhibitors
        • 12.2.1.2.1. IL-17 Inhibitors
        • 12.2.1.2.2. IL-23 Inhibitors
        • 12.2.1.2.3. Others
    • 12.2.2. Small Molecule Drugs
      • 12.2.2.1. Tyrosine kinase 2 (TYK2) inhibitors
      • 12.2.2.2. Phosphodiesterase 4 (PDE4) inhibitor
      • 12.2.2.3. Corticosteroids
      • 12.2.2.4. Retinoids
      • 12.2.2.5. Calcineurin inhibitors
      • 12.2.2.6. Others
  • 12.3. Market Value Forecast By Type, 2020 to 2035
    • 12.3.1. Branded
    • 12.3.2. Generic
  • 12.4. Market Value Forecast By Types of Psoriasis, 2020 to 2035
    • 12.4.1. Plaque Psoriasis
    • 12.4.2. Inverse Psoriasis
    • 12.4.3. Guttate Psoriasis
    • 12.4.4. Pustular Psoriasis
    • 12.4.5. Others
  • 12.5. Market Value Forecast By Route of Administration, 2020 to 2035
    • 12.5.1. Oral
    • 12.5.2. Topical
    • 12.5.3. Topical
  • 12.6. Market Value Forecast By Distribution Channel, 2020 to 2035
    • 12.6.1. Hospital Pharmacies
    • 12.6.2. Retail Pharmacies
    • 12.6.3. Online Pharmacies
  • 12.7. Market Value Forecast By Country, 2020 to 2035
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Drug Type
    • 12.8.2. By Type
    • 12.8.3. By Types of Psoriasis
    • 12.8.4. By Route of Administration
    • 12.8.5. By Distribution Channel
    • 12.8.6. By Country

13. Europe Psoriasis Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Drug Type, 2020 to 2035
    • 13.2.1. Biologics
      • 13.2.1.1. TNF Inhibitors
      • 13.2.1.2. Interleukin Inhibitors
        • 13.2.1.2.1. IL-17 Inhibitors
        • 13.2.1.2.2. IL-23 Inhibitors
        • 13.2.1.2.3. Others
    • 13.2.2. Small Molecule Drugs
      • 13.2.2.1. Tyrosine kinase 2 (TYK2) inhibitors
      • 13.2.2.2. Phosphodiesterase 4 (PDE4) inhibitor
      • 13.2.2.3. Corticosteroids
      • 13.2.2.4. Retinoids
      • 13.2.2.5. Calcineurin inhibitors
      • 13.2.2.6. Others
  • 13.3. Market Value Forecast By Type, 2020 to 2035
    • 13.3.1. Branded
    • 13.3.2. Generic
  • 13.4. Market Value Forecast By Types of Psoriasis, 2020 to 2035
    • 13.4.1. Plaque Psoriasis
    • 13.4.2. Inverse Psoriasis
    • 13.4.3. Guttate Psoriasis
    • 13.4.4. Pustular Psoriasis
    • 13.4.5. Others
  • 13.5. Market Value Forecast By Route of Administration, 2020 to 2035
    • 13.5.1. Oral
    • 13.5.2. Topical
    • 13.5.3. Topical
  • 13.6. Market Value Forecast By Distribution Channel, 2020 to 2035
    • 13.6.1. Hospital Pharmacies
    • 13.6.2. Retail Pharmacies
    • 13.6.3. Online Pharmacies
  • 13.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Switzerland
    • 13.7.7. The Netherlands
    • 13.7.8. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Drug Type
    • 13.8.2. By Type
    • 13.8.3. By Types of Psoriasis
    • 13.8.4. By Route of Administration
    • 13.8.5. By Distribution Channel
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Psoriasis Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Drug Type, 2020 to 2035
    • 14.2.1. Biologics
      • 14.2.1.1. TNF Inhibitors
      • 14.2.1.2. Interleukin Inhibitors
        • 14.2.1.2.1. IL-17 Inhibitors
        • 14.2.1.2.2. IL-23 Inhibitors
        • 14.2.1.2.3. Others
    • 14.2.2. Small Molecule Drugs
      • 14.2.2.1. Tyrosine kinase 2 (TYK2) inhibitors
      • 14.2.2.2. Phosphodiesterase 4 (PDE4) inhibitor
      • 14.2.2.3. Corticosteroids
      • 14.2.2.4. Retinoids
      • 14.2.2.5. Calcineurin inhibitors
      • 14.2.2.6. Others
  • 14.3. Market Value Forecast By Type, 2020 to 2035
    • 14.3.1. Branded
    • 14.3.2. Generic
  • 14.4. Market Value Forecast By Types of Psoriasis, 2020 to 2035
    • 14.4.1. Plaque Psoriasis
    • 14.4.2. Inverse Psoriasis
    • 14.4.3. Guttate Psoriasis
    • 14.4.4. Pustular Psoriasis
    • 14.4.5. Others
  • 14.5. Market Value Forecast By Route of Administration, 2020 to 2035
    • 14.5.1. Oral
    • 14.5.2. Topical
    • 14.5.3. Topical
  • 14.6. Market Value Forecast By Distribution Channel, 2020 to 2035
    • 14.6.1. Hospital Pharmacies
    • 14.6.2. Retail Pharmacies
    • 14.6.3. Online Pharmacies
  • 14.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. South Korea
    • 14.7.6. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Drug Type
    • 14.8.2. By Type
    • 14.8.3. By Types of Psoriasis
    • 14.8.4. By Route of Administration
    • 14.8.5. By Distribution Channel
    • 14.8.6. By Country/Sub-region

15. Latin America Psoriasis Treatment Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Drug Type, 2020 to 2035
    • 15.2.1. Biologics
      • 15.2.1.1. TNF Inhibitors
      • 15.2.1.2. Interleukin Inhibitors
        • 15.2.1.2.1. IL-17 Inhibitors
        • 15.2.1.2.2. IL-23 Inhibitors
        • 15.2.1.2.3. Others
    • 15.2.2. Small Molecule Drugs
      • 15.2.2.1. Tyrosine kinase 2 (TYK2) inhibitors
      • 15.2.2.2. Phosphodiesterase 4 (PDE4) inhibitor
      • 15.2.2.3. Corticosteroids
      • 15.2.2.4. Retinoids
      • 15.2.2.5. Calcineurin inhibitors
      • 15.2.2.6. Others
  • 15.3. Market Value Forecast By Type, 2020 to 2035
    • 15.3.1. Branded
    • 15.3.2. Generic
  • 15.4. Market Value Forecast By Types of Psoriasis, 2020 to 2035
    • 15.4.1. Plaque Psoriasis
    • 15.4.2. Inverse Psoriasis
    • 15.4.3. Guttate Psoriasis
    • 15.4.4. Pustular Psoriasis
    • 15.4.5. Others
  • 15.5. Market Value Forecast By Route of Administration, 2020 to 2035
    • 15.5.1. Oral
    • 15.5.2. Topical
    • 15.5.3. Topical
  • 15.6. Market Value Forecast By Distribution Channel, 2020 to 2035
    • 15.6.1. Hospital Pharmacies
    • 15.6.2. Retail Pharmacies
    • 15.6.3. Online Pharmacies
  • 15.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Argentina
    • 15.7.4. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Drug Type
    • 15.8.2. By Type
    • 15.8.3. By Types of Psoriasis
    • 15.8.4. By Route of Administration
    • 15.8.5. By Distribution Channel
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Psoriasis Treatment Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast By Drug Type, 2020 to 2035
    • 16.2.1. Biologics
      • 16.2.1.1. TNF Inhibitors
      • 16.2.1.2. Interleukin Inhibitors
        • 16.2.1.2.1. IL-17 Inhibitors
        • 16.2.1.2.2. IL-23 Inhibitors
        • 16.2.1.2.3. Others
    • 16.2.2. Small Molecule Drugs
      • 16.2.2.1. Tyrosine kinase 2 (TYK2) inhibitors
      • 16.2.2.2. Phosphodiesterase 4 (PDE4) inhibitor
      • 16.2.2.3. Corticosteroids
      • 16.2.2.4. Retinoids
      • 16.2.2.5. Calcineurin inhibitors
      • 16.2.2.6. Others
  • 16.3. Market Value Forecast By Type, 2020 to 2035
    • 16.3.1. Branded
    • 16.3.2. Generic
  • 16.4. Market Value Forecast By Types of Psoriasis, 2020 to 2035
    • 16.4.1. Plaque Psoriasis
    • 16.4.2. Inverse Psoriasis
    • 16.4.3. Guttate Psoriasis
    • 16.4.4. Pustular Psoriasis
    • 16.4.5. Others
  • 16.5. Market Value Forecast By Route of Administration, 2020 to 2035
    • 16.5.1. Oral
    • 16.5.2. Topical
    • 16.5.3. Topical
  • 16.6. Market Value Forecast By Distribution Channel, 2020 to 2035
    • 16.6.1. Hospital Pharmacies
    • 16.6.2. Retail Pharmacies
    • 16.6.3. Online Pharmacies
  • 16.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Drug Type
    • 16.8.2. By Type
    • 16.8.3. By Types of Psoriasis
    • 16.8.4. By Route of Administration
    • 16.8.5. By Distribution Channel
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Market Share Analysis By Company (2024)
  • 17.3. Company Profiles
    • 17.3.1. Bristol-Myers Squibb Company
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Product Portfolio
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. AbbVie Inc
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Product Portfolio
      • 17.3.2.4. Business Strategies
      • 17.3.2.5. Recent Developments
    • 17.3.3. Amgen Inc
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Product Portfolio
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. AstraZeneca
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Product Portfolio
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. Eli Lilly and Company
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Product Portfolio
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. Johnson & Johnson Services, Inc.
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Product Portfolio
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. LEO Pharma A/S
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Product Portfolio
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. Merck & Co., Inc.,
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Product Portfolio
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments
    • 17.3.9. Novartis AG
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Financial Overview
      • 17.3.9.3. Product Portfolio
      • 17.3.9.4. Business Strategies
      • 17.3.9.5. Recent Developments
    • 17.3.10. Boehringer Ingelheim Pharmaceuticals, Inc.
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Financial Overview
      • 17.3.10.3. Product Portfolio
      • 17.3.10.4. Business Strategies
      • 17.3.10.5. Recent Developments
    • 17.3.11. Arcutis Biotherapeutics, Inc
      • 17.3.11.1. Company Overview
      • 17.3.11.2. Financial Overview
      • 17.3.11.3. Product Portfolio
      • 17.3.11.4. Business Strategies
      • 17.3.11.5. Recent Developments
    • 17.3.12. Dermavant Sciences, Inc.
      • 17.3.12.1. Company Overview
      • 17.3.12.2. Financial Overview
      • 17.3.12.3. Product Portfolio
      • 17.3.12.4. Business Strategies
      • 17.3.12.5. Recent Developments
    • 17.3.13. TIEFENBACHER GROUP
      • 17.3.13.1. Company Overview
      • 17.3.13.2. Financial Overview
      • 17.3.13.3. Product Portfolio
      • 17.3.13.4. Business Strategies
      • 17.3.13.5. Recent Developments
    • 17.3.14. UCB S.A.
      • 17.3.14.1. Company Overview
      • 17.3.14.2. Financial Overview
      • 17.3.14.3. Product Portfolio
      • 17.3.14.4. Business Strategies
      • 17.3.14.5. Recent Developments
    • 17.3.15. Bausch Health
      • 17.3.15.1. Company Overview
      • 17.3.15.2. Financial Overview
      • 17.3.15.3. Product Portfolio
      • 17.3.15.4. Business Strategies
      • 17.3.15.5. Recent Developments
    • 17.3.16. Sun Pharmaceutical Industries Limited
      • 17.3.16.1. Company Overview
      • 17.3.16.2. Financial Overview
      • 17.3.16.3. Product Portfolio
      • 17.3.16.4. Business Strategies
      • 17.3.16.5. Recent Developments
    • 17.3.17. Akeso Biopharma Co., Ltd.
      • 17.3.17.1. Company Overview
      • 17.3.17.2. Financial Overview
      • 17.3.17.3. Product Portfolio
      • 17.3.17.4. Business Strategies
      • 17.3.17.5. Recent Developments
Show more
Product Code: TMRGL17960

List of Tables

  • Table 01: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035
  • Table 02: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Biologics, 2020 to 2035
  • Table 03: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Small Molecule Drugs, 2020 to 2035
  • Table 04: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
  • Table 05: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Types of Psoriasis, 2020 to 2035
  • Table 06: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
  • Table 07: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
  • Table 08: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
  • Table 09: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 10: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035
  • Table 11: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Biologics, 2020 to 2035
  • Table 12: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Small Molecule Drugs, 2020 to 2035
  • Table 13: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
  • Table 14: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Types of Psoriasis, 2020 to 2035
  • Table 15: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
  • Table 16: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
  • Table 17: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 18: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035
  • Table 19: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, By Biologics, 2020 to 2035
  • Table 20: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, By Small Molecule Drugs, 2020 to 2035
  • Table 21: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
  • Table 22: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, By Types of Psoriasis, 2020 to 2035
  • Table 23: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
  • Table 24: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
  • Table 25: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 26: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035
  • Table 27: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, By Biologics, 2020 to 2035
  • Table 28: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, By Small Molecule Drugs, 2020 to 2035
  • Table 29: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
  • Table 30: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, By Types of Psoriasis, 2020 to 2035
  • Table 31: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
  • Table 32: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
  • Table 33: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 34: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035
  • Table 35: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Biologics, 2020 to 2035
  • Table 36: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Small Molecule Drugs, 2020 to 2035
  • Table 37: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
  • Table 38: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Types of Psoriasis, 2020 to 2035
  • Table 39: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
  • Table 40: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
  • Table 41: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 42: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035
  • Table 43: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, By Biologics, 2020 to 2035
  • Table 44: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, By Small Molecule Drugs, 2020 to 2035
  • Table 45: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
  • Table 46: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, By Types of Psoriasis, 2020 to 2035
  • Table 47: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
  • Table 48: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035

List of Figures

  • Figure 01: Global Psoriasis Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 02: Global Psoriasis Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035
  • Figure 03: Global Psoriasis Treatment Market Revenue (US$ Bn), by Biologics, 2020 to 2035
  • Figure 04: Global Psoriasis Treatment Market Revenue (US$ Bn), by Small Molecule Drugs, 2020 to 2035
  • Figure 05: Global Psoriasis Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 06: Global Psoriasis Treatment Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 07: Global Psoriasis Treatment Market Revenue (US$ Bn), by Branded, 2020 to 2035
  • Figure 08: Global Psoriasis Treatment Market Revenue (US$ Bn), by Generics, 2020 to 2035
  • Figure 09: Global Psoriasis Treatment Market Value Share Analysis, By Types of Psoriasis, 2024 and 2035
  • Figure 10: Global Psoriasis Treatment Market Attractiveness Analysis, By Types of Psoriasis, 2025 to 2035
  • Figure 11: Global Psoriasis Treatment Market Revenue (US$ Bn), by Plaque Psoriasis, 2020 to 2035
  • Figure 12: Global Psoriasis Treatment Market Revenue (US$ Bn), by Inverse Psoriasis, 2020 to 2035
  • Figure 13: Global Psoriasis Treatment Market Revenue (US$ Bn), by Guttate Psoriasis, 2020 to 2035
  • Figure 14: Global Psoriasis Treatment Market Revenue (US$ Bn), by Pustular Psoriasis, 2020 to 2035
  • Figure 15: Global Psoriasis Treatment Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 16: Global Psoriasis Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 17: Global Psoriasis Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
  • Figure 18: Global Psoriasis Treatment Market Revenue (US$ Bn), by Oral, 2020 to 2035
  • Figure 19: Global Psoriasis Treatment Market Revenue (US$ Bn), by Topical, 2020 to 2035
  • Figure 20: Global Psoriasis Treatment Market Revenue (US$ Bn), by Parenteral, 2020 to 2035
  • Figure 21: Global Psoriasis Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 22: Global Psoriasis Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
  • Figure 23: Global Psoriasis Treatment Market Revenue (US$ Bn), by Hospital Pharmacies, 2020 to 2035
  • Figure 24: Global Psoriasis Treatment Market Revenue (US$ Bn), by Retail Pharmacies, 2020 to 2035
  • Figure 25: Global Psoriasis Treatment Market Revenue (US$ Bn), by Online Pharmacies, 2020 to 2035
  • Figure 26: Global Psoriasis Treatment Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 27: Global Psoriasis Treatment Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 28: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 29: North America Psoriasis Treatment Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 30: North America Psoriasis Treatment Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 31: North America Psoriasis Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 32: North America Psoriasis Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035
  • Figure 33: North America Psoriasis Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 34: North America Psoriasis Treatment Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 35: North America Psoriasis Treatment Market Value Share Analysis, By Types of Psoriasis, 2024 and 2035
  • Figure 36: North America Psoriasis Treatment Market Attractiveness Analysis, By Types of Psoriasis, 2025 to 2035
  • Figure 37: North America Psoriasis Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 38: North America Psoriasis Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
  • Figure 39: North America Psoriasis Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 40: North America Psoriasis Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
  • Figure 41: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 42: Europe Psoriasis Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 43: Europe Psoriasis Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 44: Europe Psoriasis Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 45: Europe Psoriasis Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035
  • Figure 46: Europe Psoriasis Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 47: Europe Psoriasis Treatment Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 48: Europe Psoriasis Treatment Market Value Share Analysis, By Types of Psoriasis, 2024 and 2035
  • Figure 49: Europe Psoriasis Treatment Market Attractiveness Analysis, By Types of Psoriasis, 2025 to 2035
  • Figure 50: Europe Psoriasis Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 51: Europe Psoriasis Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
  • Figure 52: Europe Psoriasis Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 53: Europe Psoriasis Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
  • Figure 54: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 55: Asia Pacific Psoriasis Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 56: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 57: Asia Pacific Psoriasis Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 58: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035
  • Figure 59: Asia Pacific Psoriasis Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 60: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 61: Asia Pacific Psoriasis Treatment Market Value Share Analysis, By Types of Psoriasis, 2024 and 2035
  • Figure 62: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, By Types of Psoriasis, 2025 to 2035
  • Figure 63: Asia Pacific Psoriasis Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 64: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
  • Figure 65: Asia Pacific Psoriasis Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 66: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
  • Figure 67: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 68: Latin America Psoriasis Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 69: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 70: Latin America Psoriasis Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 71: Latin America Psoriasis Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035
  • Figure 72: Latin America Psoriasis Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 73: Latin America Psoriasis Treatment Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 74: Latin America Psoriasis Treatment Market Value Share Analysis, By Types of Psoriasis, 2024 and 2035
  • Figure 75: Latin America Psoriasis Treatment Market Attractiveness Analysis, By Types of Psoriasis, 2025 to 2035
  • Figure 76: Latin America Psoriasis Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 77: Latin America Psoriasis Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
  • Figure 78: Latin America Psoriasis Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 79: Latin America Psoriasis Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
  • Figure 80: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 81: Middle East & Africa Psoriasis Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 82: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 83: Middle East & Africa Psoriasis Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 84: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035
  • Figure 85: Middle East & Africa Psoriasis Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 86: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 87: Middle East & Africa Psoriasis Treatment Market Value Share Analysis, By Types of Psoriasis, 2024 and 2035
  • Figure 88: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, By Types of Psoriasis, 2025 to 2035
  • Figure 89: Middle East & Africa Psoriasis Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 90: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
  • Figure 91: Middle East & Africa Psoriasis Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 92: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!